ADOPTIVE

- V2ACT Therapeutics™, LLC is a joint venture between Genelux Corporation and TVAX Biomedical, Inc. - V2ACT Immunotherapy is a proprietary immuno-oncology modality composed of Olvi-Vec (oncolytic viral immunotherapy) and TVAX…

<!-- Name:DistributionId Value:8800857 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

Seattle, Wash., April 25, 2022 (GLOBE NEWSWIRE) -- In honor of Heartworm Awareness Month, Greater Good Charities, in cooperation with Boehringer Ingelheim Animal Health, the maker of HEARTGARD® Plus (ivermectin/pyrantel), and The Animal…

Seattle, June 18, 2021 (GLOBE NEWSWIRE) -- Today, Greater Good Charities, Mars Petcare and PEDIGREE Foundation, the charitable arm of the PEDIGREE® brand, join forces to launch Good Flights “Flying to Forever Homes” initiative to airlift…